Showing results (31-40 of 62) with videos related to
Sort By:
Pageof 7
Clinical Chemistry and Laboratory Medicine|September 18, 2025
CA-125 glycovariant assays enhance diagnostic sensitivity in the detection of epithelial ovarian cancerStefanos Moukas, Katri Kuningas, Marjut Helle, et al.Therapeutic Advances in Reproductive Health|March 9, 2026
Robotic-assisted laparoscopic repair of isthmoceles: the feasibility of operative treatment and recommendations for patient selectionSa'ed Almasarweh, Rainer Kimmig, Anna Magdalena Jakob, et al.Experimental Brain Research|September 25, 2009
Timing of conditioned eyeblink responses is impaired in children with attention-deficit/hyperactivity disorderMarkus Frings, Kristina Gaertner, Paul Buderath, et al.Gait & Posture|October 31, 2008
Postural and gait performance in children with attention deficit/hyperactivity disorderPaul Buderath, Kristina Gärtner, Markus Frings, et al.Clinical Chemistry and Laboratory Medicine|November 14, 2018
Extracellular vesicle-associated miRNAs in ovarian cancer - design of an integrated NGS-based workflow for the identification of blood-based biomarkers for platinum-resistanceJan Dominik Kuhlmann, Issam Chebouti, Rainer Kimmig, et al.Cancers|August 12, 2022
Detection of <i>ESR1</i> Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma PatientsDimitra Stergiopoulou, Athina Markou, Lydia Giannopoulou, et al.Cerebellum (London, England)|May 19, 2010
Megalographia in children with cerebellar lesions and in children with attention-deficit/hyperactivity disorderMarkus Frings, Kristina Gaertner, Paul Buderath, et al.Cancers|August 7, 2019
Vesicular-Bound HLA-G as a Predictive Marker for Disease Progression in Epithelial Ovarian CancerEsther Schwich, Vera Rebmann, Peter A Horn, et al.Cerebellum (London, England)|May 20, 2009
Balance and motor speech impairment in essential tremorMartin Kronenbuerger, Jürgen Konczak, Wolfram Ziegler, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 17, 2014
[(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial resultsKarsten Beiderwellen, Johannes Grueneisen, Verena Ruhlmann, et al.Pageof 7